Advertisement

Topic - Keytruda

Related Stories

Drug Availability Illustration by Linas Garsys/The Washington Times

Congress should not punish drug innovation with weakened patent protections

By Mark Schultz and Jennifer Brant

Merck buying Terns in $6.7B deal to bolster its cancer portfolio before key Keytruda patent expires

By Michelle Chapman - Associated Press

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck &amp; Co. reports financial results Tuesday, April 30, 2019. (AP Photo/Seth Wenig, File)

Merck 1Q net quadruples as cancer drug, vaccine sales soar

By LINDA A. JOHNSON - Associated Press

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck &amp; Co. reports earnings Thursday, Oct. 25. (AP Photo/Seth Wenig, File)

Merck posts global sales of $11B in third quarter

By LINDA A. JOHNSON - Associated Press

FILE - In this Thursday, Dec.18, 2014, file photograph, scientist Christopher Kistler checks on experiments in AMBR250 bio-reactors in a laboratory at the Merck company facilities in Kenilworth, N.J. Merck &amp; Company, Inc. reports earnings, Friday, July 28, 2017. (AP Photo/Mel Evans, File)

A strong 2Q for Merck, outlook mixed

By LINDA A. JOHNSON - Associated Press